Lindy Biosciences Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
20
- Latest Deal Type
-
Series B2
- Latest Deal Amount
-
$1.96M
- Investors
-
12
Lindy Biosciences General Information
Description
Developer of a protein therapeutic platform designed for non-standard formulations such as concentration suspensions. The company's platform uses micro-glassification technology that gently removes a majority of the water from proteins or other biologics, resulting in solid, spherical, and amorphous microbeads, enabling medical professionals to return control to patients for self-administration of medications and allowing better therapies to hit the market.
Contact Information
Website
www.lindybio.comCorporate Office
- 627 Davis Drive
- Suite 400
- Morrisville, NC 27560
- United States
Corporate Office
- 627 Davis Drive
- Suite 400
- Morrisville, NC 27560
- United States
Lindy Biosciences Timeline
Lindy Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series B2) | 22-Feb-2024 | $1.96M | Completed | Generating Revenue | ||
| 7. Secondary Transaction - Private | 01-Jun-2023 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B) | 15-Jun-2022 | Completed | Generating Revenue | |||
| 5. Debt - General | 15-Apr-2020 | Completed | Product Development | |||
| 4. Early Stage VC (Series A) | 12-Mar-2019 | Completed | Product Development | |||
| 3. Angel (individual) | Completed | Startup | ||||
| 2. Grant | $800K | $200K | Completed | Startup | ||
| 1. Debt - General | 23-Aug-2017 | $200K | $200K | Completed | Startup |
Lindy Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series B | 1,275,223 | $0.001000 | $0.27 | $3.4 | $3.4 | 1x | $3.4 | 19.74% |
| Series A | 1,360,625 | $0.001000 | $0.09 | $1.24 | $1.24 | 1x | $1.24 | 21.06% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Lindy Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Lindy Biosciences Patents
Lindy Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024224038-A1 | Hyaluronidase particles, compositions comprising the same and methods of making and using the same | Pending | 20-Feb-2023 | ||
| EP-4669312-A1 | Hyaluronidase particles, compositions comprising the same and methods of making and using the same | Pending | 20-Feb-2023 | ||
| EP-4669312-A4 | Hyaluronidase particles, compositions comprising the same and methods of making and using the same | Pending | 20-Feb-2023 | ||
| WO-2024177927-A1 | Hyaluronidase particles, compositions comprising the same and methods of making and using the same | Inactive | 20-Feb-2023 | ||
| US-20260286280-A1 | Antibody compositions | Pending | 05-Feb-2019 | C12N1/02 |
Lindy Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Lindy Biosciences Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Southeast TechInventures | Accelerator/Incubator | |||
| Carolina Angel Network | Angel Group | Minority | ||
| Charleston Angel Partners | Angel Group | Minority | ||
| Fulcrum Financial Partners | Family Office | Minority | ||
| Alumshares | Growth/Expansion | Minority |
Lindy Biosciences FAQs
-
When was Lindy Biosciences founded?
Lindy Biosciences was founded in 2016.
-
Where is Lindy Biosciences headquartered?
Lindy Biosciences is headquartered in Morrisville, NC.
-
What is the size of Lindy Biosciences?
Lindy Biosciences has 20 total employees.
-
What industry is Lindy Biosciences in?
Lindy Biosciences’s primary industry is Biotechnology.
-
Is Lindy Biosciences a private or public company?
Lindy Biosciences is a Private company.
-
What is the current valuation of Lindy Biosciences?
The current valuation of Lindy Biosciences is .
-
What is Lindy Biosciences’s current revenue?
The current revenue for Lindy Biosciences is .
-
How much funding has Lindy Biosciences raised over time?
Lindy Biosciences has raised $7.52M.
-
Who are Lindy Biosciences’s investors?
Southeast TechInventures, Carolina Angel Network, Charleston Angel Partners, Fulcrum Financial Partners, and Alumshares are 5 of 12 investors who have invested in Lindy Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
